These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 489973)

  • 1. Specific 125I-iodination of cell surface lipids: plasma membrane alterations induced during humoral immune attack.
    Schlager SI
    J Immunol; 1979 Nov; 123(5):2108-13. PubMed ID: 489973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of the synthesis and release of lipids in tumor cells under attack by antibody and C.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1978 Mar; 120(3):895-901. PubMed ID: 632591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma membrane and intracellular lipid synthesis in tumor cells rendered resistant to humoral immune killing after treatment with hormones.
    Schlager SI; Ohanian SH
    J Natl Cancer Inst; 1980 Apr; 64(4):943-50. PubMed ID: 6988626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of lipids synthesized and released by tumor cells under attack by antibody and complement.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1978 May; 120(5):1644-50. PubMed ID: 659869
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of tumor cell susceptibility to humoral immune killing through chemical and physical manipulation of cellular lipid and fatty acid composition.
    Schlager SI; Ohanian SH
    J Immunol; 1980 Sep; 125(3):1196-200. PubMed ID: 7410835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeling of the lipids of chinese hamster ovary cells with the probe [3-(trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine].
    Pérochon E; Leray C; Crémel G; Hubert P
    Anal Biochem; 1997 Dec; 254(1):109-18. PubMed ID: 9398352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the ability of tumor cells to incorporate specific fatty acids and their sensitivity to killing by a specific antibody plus guinea pig complement.
    Schlager SI; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1978 Sep; 61(3):931-4. PubMed ID: 278869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell lipid composition and sensitivity to humoral immune killing. II. Influence of plasma membrane and intracellular lipid and fatty acid content.
    Schlager SI; Ohanian SH
    J Immunol; 1980 Aug; 125(2):508-17. PubMed ID: 7391566
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma membrane and intracellular lipid synthesis in tumor cells rendered sensitive to humoral immune killing after treatment with metabolic inhibitors.
    Schlager SI; Ohanian SH
    J Natl Cancer Inst; 1979 Dec; 63(6):1475-83. PubMed ID: 292816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of lipids associated with the ability of tumor cells to resist humoral immune attack.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1978 Feb; 120(2):472-80. PubMed ID: 202653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.
    Ohanian SH; Schlager SI
    Crit Rev Immunol; 1981 Jan; 1(3):165-209. PubMed ID: 6174273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for fatty acid composition of complex cellular lipids in the susceptibility of tumor cells to humoral immune killing.
    Schlager SI; Ohanian SH
    J Immunol; 1979 Jul; 123(1):146-52. PubMed ID: 448144
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipid composition of the mouse spleen in Rauscher leukaemia.
    Rédai I; Kiss J; Kása M
    Acta Microbiol Acad Sci Hung; 1975; 22(3):291-8. PubMed ID: 1057375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell membrane IgD: demonstration of IgD on human lymphocytes by enzyme-catalyzed iodination and comparison with cell surface Ig of mouse, guinea pig, and rabbit.
    Finkelman FD; van Boxel JA; Asofsky R; Paul WE
    J Immunol; 1976 Apr; 116(4):1173-81. PubMed ID: 1254967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The indiction by complement of a change in KSCN-dissociable red cell membrane lipids.
    Giavedoni EB; Dalmasso AP
    J Immunol; 1976 Apr; 116(4):1163-9. PubMed ID: 1254965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the ability of tumor cells to resist humoral immune attack and their ability to synthesize lipid.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1978 Feb; 120(2):463-71. PubMed ID: 202652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and chemical composition of subcellular fractions from tumor cells treated with metabolic inhibitors or hormones.
    Schlager SI; Ohanian SH
    Cancer Res; 1979 Apr; 39(4):1369-76. PubMed ID: 421220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in lipid characteristics of undifferentiated and enterocytic-differentiated HT29 human colonic cells.
    Reynier M; Sari H; d'Anglebermes M; Kye EA; Pasero L
    Cancer Res; 1991 Feb; 51(4):1270-7. PubMed ID: 1671756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the fatty acid profiles of red blood cell membrane phospholipids in human neonates during the first month of life.
    Pita ML; De Lucchi C; Faus MJ; Gil A
    Clin Physiol Biochem; 1990; 8(2):91-100. PubMed ID: 2361356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered thalamic membrane phospholipids in schizophrenia: a postmortem study.
    Schmitt A; Wilczek K; Blennow K; Maras A; Jatzko A; Petroianu G; Braus DF; Gattaz WF
    Biol Psychiatry; 2004 Jul; 56(1):41-5. PubMed ID: 15219471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.